By March 2025, the FDA has approved 71 biosimilars (15 interchangeable). The US & EU biosimilars markets spent $22.58 billion in 2024 & is projected to increase by 25% to $171.79 billion by 2033 https://t.co/fsqGTzWuhC https://t.co/ZLYSIwRqI4
Links:
Biosimilars Redefining Therapeutic Access: US & EU Markets on the Brink of $171…
https://buff.ly/daCiHTh
Jun-25-2025
